Hector Picon is a Cardiology physician affiliated with Harbin Clinic. OpenAlex indexes 15 publications with 288 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
504 Redmond Rd NW
Rome, GA 301651416
Telephone
706-235-3855Provider last certified this registry record 10 Jul 2025.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- Medtronic, Inc.Program year20247 payments
- ShockWave Medical, IncProgram year202410 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.5%Beta blocker19.8%Metoprolol Succinate37%Metoprolol Tartrate35%Carvedilol24%Sotalol2%Atenolol2%Bisoprolol Fumarate1%Bystolic1%Part D<11 patientsStatin13.6%Atorvastatin Calcium68%Rosuvastatin Calcium26%Pravastatin Sodium5%Simvastatin2%Part D<11 patients+ 17 more classes in this area
Blood & clotting
15.2%Factor Xa inhibitor8.6%Eliquis60%Xarelto41%Part D≥86 patientsP2Y12 inhibitor4.1%Clopidogrel85%Prasugrel Hcl10%Brilinta5%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.9%SGLT2 inhibitor3.4%Jardiance58%Farxiga42%Part D≥24 patientsPotassium supplement1.5%Potassium Chloride100%Part D≥26 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR Score
JACC: Cardiovascular Interventions
2026 - Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
European Journal of Preventive Cardiology
2026 - Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention.
Open Access CRIS of the University of Bern
2026 - 1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI
JACC: Cardiovascular Interventions
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”